Rottapharm Spain: Clinical Trials

9 trials sponsored by Rottapharm Spain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated. 6 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Terminated 2
Phase 34Completed 3, Terminated 1
Phase 12Completed 2

Follow Rottapharm Spain: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women
isoflavones combined with magnolia - Menopause
CompletedRottapharm Spain1002013-03-012014-11-05
Combined Effects of Bioactive Compounds in Lipid Profile
Armolipid Plus, placebo - Hyperlipidemia, Low-density-lipoprotein-type
Phase 2 / Phase 3CompletedRottapharm Spain1182012-01-012013-02-28
Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
Ispaghula husk, Placebo - Metabolic Syndrome
Phase 2TerminatedRottapharm Spain192008-10-012011-06-08
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
Megestrol acetate, Placebo - Dementia
Phase 2 / Phase 3TerminatedRottapharm Spain392007-06-012011-06-08
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
slow release acetyl salicylic acid, ASA, SR-ASA - Cardiovascular Disease
Phase 1CompletedRottapharm Spain502007-01-012011-06-08
Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight
Megestrol acetate, placebo - Chronic Obstructive Pulmonary Disease
Phase 2CompletedRottapharm Spain402006-10-012011-06-08
Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
Plantago ovata husk, hemicellulose crystalline - Parkinson's Disease, Idiopathic
Phase 1CompletedRottapharm Spain182006-09-012007-07-26
Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Plantago ovata husk - Hypercholesterolemia, Cardiovascular Disease
Phase 2 / Phase 3CompletedRottapharm Spain2552005-09-012007-07-17
Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
Slow release acetyl salicylic acid, Antithrombotic effect - Cardiovascular Disease
Phase 2 / Phase 3CompletedRottapharm Spain1002005-02-012007-07-18

Conditions studied

Cardiovascular Diseases (3)  ·  Metabolic Syndrome (2)  ·  Body Weight (1)  ·  Dementia (1)  ·  Hypercholesterolemia (1)  ·  Hyperlipidemias (1)  ·  Hypertriglyceridemia (1)  ·  Parkinson Disease (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Weight Loss (1)

Interventions

Megestrol Acetate (2)  ·  ispaghula seed (1)

Countries

Spain (9)

Top investigators

Eloy Rueda, MD (2)  ·  Albert Feliu, MD PhD (1)  ·  Almudena Garnica, MD (1)  ·  Angel Brea, MD (1)  ·  Anna Anguera, MD, PhD (1)  ·  Carriedo Demetrio, MD (1)  ·  Enrique Arriola, MD (1)  ·  Eric Brucker, MD, phD (1)  ·  Esperanza Martin, MD (1)  ·  Gloria Bueno, MD, PhD (1)  ·  Herrejon Alberto, MD (1)  ·  Joan Bel, MD, PhD (1)

Results publications

PMID 21524765, PMID 23840361, PMID 25084280